Bottom line
KURE vs IXUS: the short answer
KURE (KraneShares MSCI All China Health Care Index ETF) and IXUS (iShares Core MSCI Total International Stock ETF) are both etfs.
But IXUS is far broader, holding 4,530 positions to 63 for KURE, so beyond the top names it adds exposure KURE doesn't have.
IXUS is cheaper at 0.07% vs 0.65% — a difference of $58 a year per $10,000 invested.
Over five years, IXUS returned +4.2% a year vs −11.8% for KURE (reporting dates differ).
Updated Nov 19, 2026
KURE vs IXUS side by side
| KURE | IXUS | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Krane Shares | iShares |
| Category | Health Care Sector | International Stock |
| Expense ratio | 0.65% | 0.07% |
| Annual cost per $10k | $65 | $7 |
| 10-yr cost on $10k (prospectus) | $951 | $90 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +24.8% | +5.1% |
| 5-yr return (annualized) | −11.8% | +4.2% |
| 10-yr return (annualized) | — | +5.0% |
| Best quarter | +33.4% | +17.2% |
| Worst quarter | −23.4% | −24.1% |
| Net assets (fund) | $71.2M | $58.4B |
| Number of holdings | 63 | 4,530 |
| Portfolio turnover | 73% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | KURE | IXUS | Difference |
|---|---|---|---|
| 2024 | −17.4% | +5.1% | −22.6% |
| 2023 | −17.3% | +15.6% | −32.9% |
| 2022 | −25.4% | −16.4% | −9.0% |
| 2021 | −15.9% | +8.5% | −24.4% |
| 2020 | +67.3% | +11.1% | +56.1% |
| 2019 | +34.0% | +21.9% | +12.2% |
Source: Fund prospectus bar charts
Holdings overlap
KURE and IXUS share none of their top holdings.
KURE top 10
- BeOne Medicines AG — 8.84%
- Innovent Biologics, Inc. — 8.80%
- Wuxi Biologics (cayman) Inc. — 7.51%
- WuXi AppTec Co., Ltd. — 5.79%
- Jiangsu Hengrui Pharmaceuticals Co.,Ltd — 4.59%
- Shenzhen Mindray Bio-Medical Electronics Co Ltd — 4.27%
- Akeso Inc — 3.72%
- Cspc Pharmaceutical Group Limited — 3.68%
- Invesco Government & Agency Portfolio — 3.55%
- Sino Biopharmaceutical Limited — 3.39%
IXUS top 10
- Taiwan Semiconductor Manufacturing Company Limited — 4.29%
- Samsung Electronics Co., Ltd. — 1.92%
- ASML Holding N.V. — 1.51%
- SK hynix Inc. — 1.48%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.41%
- Tencent Holdings Limited — 0.88%
- Hsbc Holdings Plc — 0.86%
- Roche Holding AG — 0.72%
- Royal Bank Of Canada — 0.69%
- Novartis AG — 0.68%
FAQ
What is the difference between KURE and IXUS?
Which is cheaper, KURE or IXUS?
Should I own both KURE and IXUS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.